Patients with steroid refractory acute vascular rejection develop agonistic antibodies targeting angiotensin II type 1 receptor

« Previous Next »Transplantation Proceedings
Volume 35, Issue 6 , Pages 2104-2105, September 2003

D Dragun
- Department of Nephrology Medical Faculty of the Charité Campi Mitte (D.D., L.F., K.B., H.-H.N), Berlin, Germany
- Address reprint requests to Duska Dragun, Ass. Professor of Medicine, Nephrology, Charite Campus Mitte, Humboldt University, Schumannstr. 20/21, 10117 Berlin, Germany.
J.H Bräsen
- Department of Buch (J.H.B., F.C.L.), Humboldt University of Berlin, Berlin, Germany
C Schönemann
- HLA-Laboratory Virchow-Klinikum (C.S.), Berlin, Germany
L Fritsche
- Department of Nephrology Medical Faculty of the Charité Campi Mitte (D.D., L.F., K.B., H.-H.N), Berlin, Germany
K Budde
- Department of Nephrology Medical Faculty of the Charité Campi Mitte (D.D., L.F., K.B., H.-H.N), Berlin, Germany
H.-H Neumayer
- Department of Nephrology Medical Faculty of the Charité Campi Mitte (D.D., L.F., K.B., H.-H.N), Berlin, Germany
F.C Luft
- Department of Buch (J.H.B., F.C.L.), Humboldt University of Berlin, Berlin, Germany
G Wallukat
- Max Delbrück Center for Molecular Medicine, (G.W.), Berlin, Germany